KLK3 and prostate cancer: Ki = 72 nM. Eight times more selective compared to chymotrypsin (Ki = 580 nM). Reduction in free and total KLK3 serum levels in human prostate cancer xenografts produced in nude mice upon intravenous administration of 10 mg/kg dose for three cycles of five consecutive days/week [130]